Felix Wang

Independent Consultant @ Self-Employed

Country

China

City

Shanghai

Industry

Biotechnology

Skill

Biopharmaceuticals, Tumor Immunology, Validation (Drug Manufacture), Program Oversight, Proof of Concept, Drug Discovery, Precision Medicine, Biomarker Development, Molecular Immunology, Anti-inflammatory, CRO Management, Cancer Immunotherapy, Cellular Assays, Program Analysis, In Vitro, RNAseq Analysis, Strategic Consulting, Translational Research, Strategy Consulting

Experience

Independent Consultant

Self-Employed

2024-7 - Present · 2 yrs 3 mos

Provided strategic consulting and implementation with CRO outsourcing for early-stage drug discovery programs.

Head of Biology

IntelliGen Therapeutics

2022 - 2024 · 2 yrs

Led discovery biology and translational research, achieving preclinical PoC for emerging programs in Oncology and immune-mediated diseases. Managed CROs and designed in vitro and in vivo studies for PoC, efficacy and PK/PD evaluation.

Director Biology

Hengrui Pharma

2021 - 2022 · 1 yr

Advanced two therapeutic antibody programs to PCC nomination in Oncology and autoimmune diseases. Directed comprehensive in vitro and in vivo studies, aligning research with translational goals.

Principal Scientist

Black Diamond Therapeutics

2020 - 2021 · 1 yr

Directed mutant-specific oncology programs and HTS campaigns. Demonstrated PoC for mutant-selective compounds in safety and efficacy studies.

Principal Investigator

Incyte

2018 - 2020 · 2 yrs

Developed and validated advanced cell-based assays for HTS and SAR screening. Built in-house methods for HTRF, AlphaLisa, and ex vivo assays and developed cell lines for both in vitro and in vivo studies.

Senior Scientist

NewLink Genetics

2016 - 2018 · 2 yrs

Spearheaded novel small molecule discovery programs for cancer immunotherapy. Conducted MoA studies using RNA-seq, affinity precipitation, and pathway analysis.